Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium
British Journal of Haematology · 2026-01 · 208 (1) · 250-258
DOI: 10.1111/bjh.19691 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Haematology, online erschienen am 19.08.2024. Verfasst von Flore Sicre de Fontbrune und 20 weiteren Autor:innen. Beteiligte Einrichtung: Hématologie Greffe, Hôpital Saint-Louis, APHP, Paris, France. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, GATA2 Deficiency. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Modalities and timing of haematopoietic stem cell transplant (HSCT) in patients with GATA2 deficiency are still subject to debate. On June 2022, 67 patients (median age 20.6 years) underwent a first allogeneic HSCT among 21 centres. Indications for HSCT were myelodysplastic syndrome (MDS) ≤5% blasts ± immunodeficiency (66%), MDS >5% blasts (15%), acute myeloid leukaemia (19%). Conditioning regimen was myeloablative in 85% and anti‐thymocyte globulins were used in 67%. The cumulative incidence (CInc) of acute graft versus host disease (GvHD) grade II–IV and III–IV at day 100 were 42% and 13%, and CInc of chronic and extensive chronic GvHD at 2 years were 42% and 23%. CInc of relapses was 3% and 11% at 1 and 5 years. Overall survival (OS) at 1 and 5 years was 83% and 72% (median follow‐up 5.6 years). The factors associated with worse OS in multivariable analysis were the year of HSCT, a history of excess blasts before transplant and peripheral blood stem cell (PBSC) grafts. Age at HSCT, non‐myeloablative conditioning and PBSC grafts were associated with increased non‐relapse mortality. In conclusion, bone marrow monitoring to identify clonal evolution and perform HSCT before the appearance of excess blast is mandatory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hématologie Greffe, Hôpital Saint-Louis, APHP, Paris, France.
- AJA, Hôpital Saint Louis, APHP, Paris, France.
- Service d'Hématologie Pédiatrique, Hôpital Robert Debré, APHP, Paris, France.
- DBIM, Hôpital Saint Louis, APHP, Paris, France.
- Adult Hematology, Clinique Universitaire Saint Luc, Bruxelles, Belgium.
- Hématologie Adulte, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France.
ORCID-Profile: Flore Sicre de Fontbrune, Edouard Forcade, Ambroise Marcais, Regis Peffault de Latour
Zitieren
APA
Sicre de Fontbrune, F., Chevillon, F., Fahd, M., Desseaux, K., Poiré, X., Forcade, E., Sterin, A., Neven, B., Gandemer, V., Thepot, S., Garnier, A., Lioure, B., Marcais, A., Nguyen-Quoc, S., Tavitian, S., Vincent, L., Donadieu, J., Resche Riggon, M., Chevret, S., …, & Peffault de Latour, R. (2026). Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium. British Journal of Haematology, 208(1), 250-258. https://doi.org/10.1111/bjh.19691
Vancouver
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poiré X, Forcade E, et al. Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium. British Journal of Haematology. 2026;208(1):250-258. doi:10.1111/bjh.19691
BibTeX
@article{SicredeFontbrune2026,
author = {Sicre de Fontbrune, Flore and Chevillon, Florian and Fahd, Mony and Desseaux, Kristell and Poiré, Xavier and Forcade, Edouard and Sterin, Arthur and Neven, Bénédicte and Gandemer, Virginie and Thepot, Sylvain and Garnier, Alice and Lioure, Bruno and Marcais, Ambroise and Nguyen-Quoc, Stephanie and Tavitian, Suzanne and Vincent, Laure and Donadieu, Jean and Resche Riggon, Matthieu and Chevret, Sylvie and Pasquet, Marlene and Peffault de Latour, Regis},
title = {Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {1},
pages = {250--258},
doi = {10.1111/bjh.19691}
}
EUVIMED